Currently ordering online is available only to our wholesale distributors.
We will soon have an online store for the general public
Arthrivite Gold is a superior nutritional formula for many of the arthritides. It is a combination of highly researched vitamins, minerals and botanicals blended in the correct proportions to support and promote long term joint tissue health. As well, Arthrivite Gold safely and effectively addresses the debilitating symptoms of inflammation and pain. Arthrivite Gold is designed to treat a wide variety of clinical concerns that involve the degenerative assault on the joints and the adjoining effected soft tissues.
Product Info
Arthrivite Gold is designed for long-term treatment for joint support and maintenance. It is best to start with two capsules three times per day for an initial 6 to 8 week period. Thereafter, there may be a reduction in dosing, determined by an evaluation of the clinical condition by your health care practitioner. Arthrivite Gold is best taken with a meal.
Ingredients
updating
References
Study: Kaufman The use of vitamin therapy to reverse certain concomitants of aging. J. Am Geriatr Soc 3:927 1955. Abstract: 663 patients receiving niacinamide were shown to have superior scores on an index of joint range movement that 842 untreated age-matched patients. week trial, Study: Simkin, P.A. Oral zinc sulfate in rheumatoid arthritis. Lancet 2:539-42 1976. Abstract: In this double blind study, 12 of the 24 patients with chronic rheumatoid arthritis received 50 mg elemental zinc from sulfate three times daily with meals for 12 weeks and the remaining 12 patients received placebo. Following this, all 24 patients received zinc for 12 more weeks. There were significant improvements in joint swelling, morning stiffness, walking time and subjective symptoms during the first part of the study, with continued improvement in the second 12 week period. Study: Clemmensen, O.J. Psoriatic arthritis treated with oral zinc sulfate. British Jour of Derm 103: 411-15 1980 Abstract: In this double blind study patients negative for rheumatoid factors, LE cells and anti-nuclear antibodies experienced reduction in signs and symptoms of rheumatoid arthritis following supplementation with zinc sulfate at 220 mg three times per day for 6 weeks. At the end of this period of time, serum immunoglobulins decreased and serum albumin increased. Joint pains were significantly reduced following the initial study. In a subsequent 24 week trial, morning stiffness lessened significantly and overall conditions improved appreciably. The psoriatic lesions did not change during this study. Reference: W.Wang - N.Ballatori; Pharmacological Reviews; Vol 50 No 3, 335-342 , 1998. Reference: Linus Pauling Institute, Micronutrient Center, OSU, 2007. Study: Vaz, A.I. Double blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulfate in the management of osteoarthritis of the knee in out-patients; Curr Med Res Opin 8, 145-149, 1983. and had no side effects. Study: Tapidinhas, M.J. Oral glucosamine sulfate in the management of arthrosis: Report on a multi-center open investigation in Portugal; Pharmatherapeutica 3, 157-168, 1982. Study: McCarty, M.F. Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis, Med Hypothesis, (54) 5, 798-802, 2000. Study: Uebelhart, D. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study, Osteoarthritis and Cartilage, 6, 39-46, 1998. Abstract: A double blind study of 42 patients with osteoarthritis of the knee were treated with 800 mg of a proprietary product containing chondroitin sulfate or a placebo for a period of one year. Pain, mobility and joint width were measured. At three months, pain was significantly reduced in the chondroitin group compared to placebo, and more pain reduction was noted at twelve months. Mobility in the chondroitin group was increased at six months from start, and again further improvement was noted at twelve months when compared to placebo. At one year, the width of the femorotibial joint was significantly decreased in the placebo group, however, it was unchanged in the group consuming chondroitin. It appears that long term use of chondroitin may slow the progression of osteoarthritis. Study: Ammon, H.P.T. Mechanism of anti-inflammatory actions of curcumin and boswellic acids, Ethnopharmacology 38, 113-119, 1993. Abstract: This study analyzes the in vitro anti-inflammatory effects of extracts of Curcuma longa and of Boswellia serrata, a second botanical species. The activities of the enzymes 5-lipoxygensase, cyclooxygenase, and 12-lipoxygenase were tracked after applications of curcumin and boswellic acid extracts. Curcumin, possibly through its antioxidant activity, inhibits these three enzymes of arachidonic acid metabolism, limiting pro-inflammatory developments. The boswellic acid acted as an inhibitor of 5-lipoxygenase activity. Reference: Brien, S. et al, Bromelain as a treatment for Osteoarthritis, Evid Base Comp Alt Med, 1.3, 251-257, 2004. Study: Etzel,R. Special extract of Boswellia serrata in the treatment of rheumatoid arthritis, Phytomedicine, 3.1, 91-94, 1996. Abstract- This analysis assessed the effect of boswellic acid in persons with rheumatoid arthritis, juvenile rheumatoid arthritis, and osteoarthritis of the knee. The parameters used for assessment of the effects from the boswellic acid included joint swelling, joint pain, erythrocyte sedimentation rate ESR measurements, morning stiffness, additional use of NSAIDS, general health and well being, side effects and tolerance levels. There was a significant decrease in swelling and in pain threshold, as well as improvement in ESR level. Morning stiffness decreased. NSAID use decreased. There were fewer incidences of the need for emergency treatment for symptom control. Treatment protocols were well tolerated. Grzanna, R. et al, Ginger- an herbal medicinal product with broad anti-inflammatory actions, J Med Food, 8.2, 125-32, 2005. Twenty patients were studied in this trial; ten participants ingested 6 mg of boron per day and another ten participants used placebo. The boron was administered in two tablets containing 25 mg of sodium tetraborate decahydrate. Five of the patients on boron showed significant improvement after an eight week regimen. Only one of the placebo group manifest improvement. There were no side effects.
Updating...
